Taking into account predicted deleterious effects and associations of the affected gene with epilepsy or intellectual disability in these candidate variants revealed two novel compound heterozygous mutations in the gene ACO2 (NM_001098) [2] (Fig 1). This evidence concerns the gene ACO2 and epilepsy.